| # | Drug | Count |
|---|---|---|
| 0 | NILOTINIB | 16 |
| 1 | ADALIMUMAB | 11 |
| 2 | ATORVASTATIN CALCIUM | 11 |
| 3 | PANTOPRAZOLE | 11 |
| 4 | ASPIRIN | 10 |
| 5 | ASPIRIN 325 MG | 10 |
| 6 | ASPIRIN 81 MG | 10 |
| 7 | EZETIMIBE | 10 |
| 8 | PREDNISOLONE | 10 |
| 9 | PREDNISOLONE ORAL | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE | 1 | 0.0076 |
| 1 | DICLOFENAC SODIUM/MISOPROSTOL | 1 | 0.0023 |
| 2 | NICARDIPINE HYDROCHLORIDE | 4 | 0.0018 |
| 3 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 1 | 0.0016 |
| 4 | NICARDIPINE | 4 | 0.0009 |
| 5 | INFLIXIMAB-AXXQ | 1 | 0.0009 |
| 6 | PSYLLIUM HUSK | 1 | 0.0007 |
| 7 | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES | 1 | 0.0006 |
| 8 | NILOTINIB | 16 | 0.0005 |
| 9 | OMEGA-3-ACID ETHYL ESTERS | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 3 | 0.0016 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | PCSK9 Inhibitor [EPC] | 9 | 0.0003 |
| 3 | Phosphodiesterase 3 Inhibitor [EPC] | 2 | 0.0003 |
| 4 | Dopamine-2 Receptor Antagonist [EPC] | 2 | 0.0003 |
| 5 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 6 | 0.0002 |
| 6 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 7 | Chloride Channel Activator [EPC] | 2 | 0.0002 |
| 8 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |
| 9 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |